Low rate of infectious complications following immunoadsorption therapy without regular substitution of intravenous immunoglobulins

Immunoadsorption leads to a significant reduction of IgG. CRP as inflammatory marker is not affected. Even without substitution of IVIG the complication rate directly linked with IA is low and questionable.